Literature DB >> 6759123

Regulation of rat liver L-type pyruvate kinase mRNA by insulin and by fructose.

T Noguchi, H Inoue, T Tanaka.   

Abstract

The effects have been studied of streptozotocin-induced diabetes and subsequent insulin administration or feeding of a high fructose diet on the amount of enzyme protein and mRNA activity of L-type pyruvate kinase in rat liver. Diabetes markedly decreased the L-type enzyme activity in rat liver and insulin treatment resulted in restoration of the enzyme activity to normal. A high fructose diet also increased the enzyme activity in diabetic rats but to a lesser extent. Immunochemical analysis showed that these alterations in the enzyme activity were due to changes in the amount of immunoreactive enzyme protein. The mechanism of the changes was studied further by assaying the level of functional mRNA coding for this enzyme in a nuclease-treated reticulocyte lysate system with total RNA isolated from rat liver. L-type pyruvate kinase mRNA, expressed as a percentage of the total protein synthesized, was greatly decreased in diabetic rats. Insulin administration resulted in recovery of the mRNA activity to the normal level within 24 h. The lag period before accumulation of translatable mRNA of the L-type enzyme was about 4-5 h. The mRNA activity was also increased in diabetic rats fed a high fructose diet. This fructose effect, which was much smaller than the insulin effect, was maximal after feeding fructose diet for one day. These changes were approximately comparable to the changes in enzyme activity. Thus, it is suggested that regulations of rat liver L-type pyruvate kinase by insulin and by fructose are primarily due to changes in the level of translatable mRNA of this enzyme.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6759123     DOI: 10.1111/j.1432-1033.1982.tb07004.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Regulation of glucose-6-phosphate dehydrogenase synthesis and mRNA abundance in cultured rat hepatocytes.

Authors:  P Manos; R Nakayama; D Holten
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Inhibition of gastrin gene expression by somatostatin.

Authors:  P S Karnik; S J Monahan; M M Wolfe
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

3.  Expression of mouse phosphofructokinase-M gene alternative transcripts: evidence for the conserved two-promoter system.

Authors:  H Nakajima; T Noguchi; T Hamaguchi; K Tomita; T Hanafusa; N Kono; T Tanaka; M Kuwajima; Y Matsuzawa
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

4.  Insulin regulation of rat growth hormone gene transcription.

Authors:  S Yamashita; S Melmed
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

Review 5.  Nutrient and hormonal regulation of pyruvate kinase gene expression.

Authors:  K Yamada; T Noguchi
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

6.  Metabolic actions of insulin-like growth factor II in cultured adult rat hepatocytes are not mediated through the insulin-like growth factor II receptor.

Authors:  H Hartmann; A Meyer-Alber; T Braulke
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

7.  Oral administration of vanadate to diabetic rats restores liver 6-phosphofructo-2-kinase content and mRNA.

Authors:  M Miralpeix; E Carballo; R Bartrons; K Crepin; L Hue; G G Rousseau
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

8.  Biological activity of des-(B26-B30)-insulinamide and related analogues in rat hepatocyte cultures.

Authors:  H Hartmann; K Oberhaus; R Spahr; D Brandenburg; W Creutzfeldt; I Probst
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

9.  Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice.

Authors:  L Osborn; M P Rosenberg; S A Keller; M H Meisler
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

Review 10.  The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease.

Authors:  J Bernadette Moore; Pippa J Gunn; Barbara A Fielding
Journal:  Nutrients       Date:  2014-12-10       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.